Mesothelioma

Dr. Travis Grotz explains how hyperthermic intraperitoneal chemotherapy works and how it can help patients with certain late-stage cancers.

Mayo Clinic researchers may have discovered a genomic signature to predict which people with mesothelioma could benefit from immunotherapy.